Tff Pharmaceuticals Inc

NASDAQ:TFFP   3:59:30 PM EDT
9.25
+0.27 (+3.01%)
Products, Regulatory

TFF Announces Topline Results Of Voriconazole Inhalation Powder Phase 1 Clinical Trial

Published: 09/15/2020 13:07 GMT
Tff Pharmaceuticals Inc (TFFP) - Tff Pharmaceuticals Announces Topline Results of Voriconazole Inhalation Powder Phase 1 Clinical Trial.
Tff Pharmaceuticals - Will Now Advance Voriconazole Inhalation Powder Into Phase 2 Studies.
Tff Pharmaceuticals - Investigating Potential Treatment Or Prevention of Covid-19 Associated Pulmonary Aspergillosis, Other Pulmonary Fungal Infections.